Back
Neurogene, Inc. Stock Price Chart
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
10
NGNE
Neurogene, Inc.
Last Price:
$17.20
Seasonality Move:
-7.5%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Neurogene, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.81 | Sell |
| 20-day SMA: | 18.06 | Sell |
| 50-day SMA: | 19.32 | Sell |
| 200-day SMA: | 20.74 | Sell |
| 8-day EMA: | 14.34 | Buy |
| 20-day EMA: | 8.81 | Buy |
| 50-day EMA: | 4.29 | Buy |
| 200-day EMA: | 1.19 | Buy |
Neurogene, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.71 | Buy |
| Relative Strength Index (14 RSI): | 43.02 | Sell |
| Chaikin Money Flow: | 55056 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.3 - 19.2) | Sell |
| Bollinger Bands (100): | (17.03 - 27.75) | Sell |
Neurogene, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurogene, Inc. Stock
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 17.23 while NGNE 8-day simple moving average is 17.81, which is a Sell signal.
-
The stock price of NGNE is 17.23 while Neurogene, Inc. 20-day SMA is 18.06, which makes it a Sell.
-
Neurogene, Inc. 50-day simple moving average is 19.32 while NGNE share price is 17.23, making it a Sell technically.
-
NGNE stock price is 17.23 and Neurogene, Inc. 200-day simple moving average is 20.74, creating a Sell signal.
NGNE Technical Analysis vs Fundamental Analysis
Sell
10
Neurogene, Inc. (NGNE)
is a Sell
Is Neurogene, Inc. a Buy or a Sell?
-
Neurogene, Inc. stock is rated a SellThe current Neurogene, Inc. [NGNE] share price is $17.23. The Score for NGNE is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
Neurogene, Inc. Stock Info
Market Cap:
266.9M
Price in USD:
17.23
Share Volume:
91.2K
Neurogene, Inc. 52-Week Range
52-Week High:
37.27
52-Week Low:
6.88
Sell
10
Neurogene, Inc. (NGNE)
is a Sell
Neurogene, Inc. Share Price Forecast
-
What is the Neurogene, Inc. stock price today?The Neurogene, Inc. stock price is 17.23 USD today.
-
Will NGNE stock go up or go down?Neurogene, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurogene, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurogene, Inc. is overvalued.
Is Neurogene, Inc. Stock a Buy?
-
Neurogene, Inc. share price is 17.23 while NGNE 8-day exponential moving average is 14.34, which is a Buy signal.
-
The stock price of NGNE is 17.23 while Neurogene, Inc. 20-day EMA is 8.81, which makes it a Buy.
-
Neurogene, Inc. 50-day exponential moving average is 4.29 while NGNE share price is 17.23, making it a Buy technically.
-
NGNE stock price is 17.23 and Neurogene, Inc. 200-day simple moving average is 1.19, creating a Buy signal.
Fundamental Analysis of Neurogene, Inc.
Is Neurogene, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.62 per share.
Technical Analysis of Neurogene, Inc.
Should I short Neurogene, Inc. stock?
-
NGNE Moving Average Covergence Divergence (MACD) indicator is 4.71, suggesting Neurogene, Inc. is a Buy
-
Neurogene, Inc. Relative Strength Index (RSI) is 43.02, which suggest Neurogene, Inc. is oversold
-
The Bollinger Bands (25) for Neurogene, Inc. is (17.3 - 19.2), which suggest Neurogene, Inc. is a Sell
-
The Bollinger Bands (100) for Neurogene, Inc. is (17.03 - 27.75), which suggest Neurogene, Inc. is a Sell
* Neurogene, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.